Gastrointestinal Endoscopy Devices – Market Insights – Europe

The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer screening programs that expand the eligible patient pool. In parallel, incremental innovation in GI videoscope systems and the incorporation of AI will contribute to modest growth over the forecast period. However, downward pressure from ASP erosion and limited innovation in certain mature segments will temper the market’s overall growth trajectory.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Europe from 2019 through 2035.

The introduction and implementation of updated CRC screening guidelines will affect certain markets within the GI endoscopy device space.

How will updated CRC screening guidelines affect GI endoscopy procedure volumes?

How does Europe’s CRC screening approach influence GI device recommendations, and what impact does this have on endoscopy procedures and devices?

Which market segment will see a boom in growth due to these screening guidelines in place, and how?

AI and CAD are expanding the possibilities for innovation within the GI endoscopy device market in Europe.

Which companies are already providing AI-integrated products, and how will they shape the GI endoscopy device market?

What AI or CADenabled products are likely to be introduced to the market in the near term?

How will the adoption of AI and CADenabled technologies shape clinical workflows, diagnostic performance, and market dynamics in GI endoscopy?

The European GI endoscopy device market is diverse, comprising both large MNCs and regional domestic manufacturers.

Which manufacturers benefit from bundling capital equipment with consumables?

Which manufacturers are struggling to sustain their presence in the European GI endoscopy device market?